Human newborns are susceptible to severe infections with HSV (1) and those who recover have low frequencies of HSV specific responder T cells in their blood (2). The frequency of HSV-responder T cells in normal newborns is low (less than 1:106) (3) and host defense is thought to depend primarily on antibody passively acquired from the mother and on nonspecific effector mechanisms including the production of interferons and NK cells (4). Leukocyte (or a ) interferon is made in equivalent amounts by human newborn and adult blood MNC stimulated by HSV (5). Less is known of y-interferon, which is made by T cells (6, 7) and NK cells (8). This lymphokine has a wide range of biologic activities (9) including suppression of cell growth and herpes virus replication and the amplification of NK lysis of virus-infected target cells. Previous studies indicate that newborn blood MNC have a low frequency of T cells which make yinterferon spontaneously (10) and that they release less ?-interferon in response to phytohemogglutinin (1 1, 12), Concanavalin A, or OKT 3 antibody (Ortho Diagnostic Systems, Raritan, NJ) (12) than adult MNC unless the newborn MNC are first irradiated (12) or, in Taylor & Bryson's study (1 I), the newborn monocytes were replaced by adult monocytes. Phytohemogglutinin and Concanavalin A activate a wide range of cells so the existing data give no indication of the relative ability of newborn and adult NK cells to respond to a herpes virus stimulus. We
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MATERIALS AND METHODS
Blood samples. Newborn blood was obtained from the placental end of the cut cord of healthy newborn deliveries and adult blood from healthy volunteers. Blood samples were anticoagulated with 10 U/ml heparin and the red cells in the newborn samples were sedimented with a 30-min incubation with 1.5% Hetastarch (Hespan, American Hospital Supply Corp, Irvine, CA). MNC were separated on Ficoll-Hypaque gradients and washed twice in HBSS before being adjusted to 106/ml in RPMI 1640 medium supplemented with 40 ~g / m l gentamicin and 10% human serum.
MNC were depleted of Leu 1 1 + cells by complement mediated lysis using 8 ~1 Leu 1 1 b (Becton Dickinson Monoclonal Antibodies, Mountain View, CA) per lo7 cells and a 45-min incubation at room temperature, followed by 45 min in a 1:6 dilution of complement (Low-tox-H rabbit complement, Cedarlane Labs, Ontario, Canada) as recommended (Becton Dickinson Source Book, section 4.31). This procedure killed about 20% of the MNC and subsequent staining with Leu 1 la indicated that over 80% of Leu 11' cells were killed. Depletion of monocytes was by adherence to Sephadex G 10 as described by Ly and Mishell (13) . Enrichment of NK cells was by Percoll (Sigma Chemical Co, St. Louis, MO, made isotonic with 10% of l o x HBSS) density gradient centrifugation (14) with discontinuous steps (7 x 5%, from 60 to 30%). MNC depleted of adherent cells were resuspended in HBSS and loaded at the top of the gradient for 30 min centrifugation at room temperature at 550 x g. Cells were counted after all the depletion/enrichment steps and readjusted to 106/ml.
Cell cultures with HSV or IL 2 were in Falcon 2056 tubes, loosely capped, in a COz incubator for 3 days, after which the cells were spun down and the supernatant recovered and kept frozen at -20" C until assayed. The 3-day culture period was selected as optimal for ?-interferon production on the basis of the results of Pearlstein et al. (1 5) .
HSV (Kos strain) was kindly provided by Dr. L. Pizer and grown in rabbit skin cells at confluence in Dulbecco's minimal essential medium with 2% fetal calf serum. Infected monolayers showing complete cytopathic effect were harvested and sonicated, the cell debris was spun down at 200 x g for 10 min. Virus was stored at -70" C and contained lo7 plaque forming units/ml by a plaque assay on rabbit skin cells.
IL 2 was purchased from AmGen (Thousand Oaks, CA), lots 103 at 2 U/ng and 104 at 10 U/ng, and was diluted to 10 U/ml in RPMI 1640.
Gamma-interferon assay was by the double antibody radioimmunoassay (IMRX, Centocor Labs, Malvern, PA). The assay 399 was calibrated with the standards provided. There was a linear relationship between the y-interferon concentration and cpm of 1251 bound in all assays (correlation coefficient greater than 0.98). Gamma-interferon concentrations in the tissue culture supernatants were calculated by linear estimation using Abstat software (Anderson-Bell, Canon City, CO).
Cells were phenotyped by immunofluorescent staining with fluorescein conjugated Leu 1 la (Becton Dickinson Monoclonal Antibodies, 5 p1/106 cells) and phycoerythrin conjugated anti-IL 2 receptor antibody (no. 7647, Becton Dickinson Monoclonal Antibodies). The cells were washed three times in HBSS with 0.1 % sodium azide and 0.1 % bovine serum albumin and were fixed in 2% paraformaldehyde. Analysis was on a Coulter EPICS C using the Quadstat program. 
RESULTS * lo6 cells were incubated for 3 days when supernatant y-interferon
Stimulation of y-interferon production by HSV and IL 2.
In preliminary experiments the ability of different concentrations of IL 2 or HSV to elicit y-interferon production by newborn MNC were compared. The results (Fig. 1) indicate that unstimulated newborn MNC do not make detectable amounts of yinterferon in their first 3 days of culture and that in the presence of IL 2 alone small amounts (up to 10 U/ml) of y-interferon are detected in proportion to the IL 2 concentration. Newborn MNC cultures stimulated with live HSV alone made small amounts (mean 3 U/ml) of y-interferon without any HSV concentration relationship over the range tested. Combinations of HSV and IL 2 made more y-interferon than either stimulus alone. On the basis of these results we selected 10 U/ml of IL 2 as a suboptimal concentration at which we could compare y-interferon production by newborn and adult MNC in the presence of HSV. The resuts (Table 1) are consistent with those in Figure 1 and show that only MNC from immune donors made substantial amounts of y-interferon (up to 110 U/ml) in cultures stimulated with HSV alone. Cultures of nonimmune adult and newborn MNC made little y-interferon in response to HSV or to 10 U/ml IL 2 but there was a synergistic effect with production of a mean of 53 U/ml in newborn cultures containing both IL 2 and 1. In a separate series of experiments (not shown in Table 1 ) killed HSV was used with 10 U/ml of IL 2 as the stimulus for y-interferon production by adult immune donor MNC. These cultures gave less y-interferon (mean 54 U/ml) than cultures using live HSV (mean 100 U/ml). For subsequent experiments we used only the live virus preparations.
Gamma-interferon is known to be made by T lymphocytes (7) was measured by radioimmunoassay. All cultures were in I-ml volumes; IL 2 concentration = 10 U/ml, HSV = lo6 PFU/ml, n = number of samples assayed. and NK cells (8) . We have previously shown that the frequency of herpes virus responder T cells in newborn and adult nonimmune donors is very low ( t l in lo6 and 1: lo5, respectively) so it was very unlikely that T cells were the origin of y-interferon in our newborn cultures. To test the requirement for the Leu 11+ subset of NK cells, we selectively depleted adult and newborn MNC subsets with Leu 1 l b and complement before stimulation with IL 2 and HSV.
Requirement for monocytes and Leu ll+ cells for HSV + IL 2 stimulated y-interferon production by nonimmune donors' MNC.
Depletion of Leu 1 I+ cells from the MNC reduced the amount of y-interferon made in all HSV + IL 2 stimulated cultures. The reduction was proportionally greatest (10-fold) in the newborn samples. To determine whether monocytes were necessary for yinterferon production in response to HSV and IL 2 we depleted MNC preparations of adherent cells by passage over Sephadex G 10. Paradoxically, the y-interferon production by these preparations was raised even without further stimulus and the addition of IL 2 alone gave maximal production. in MNC cultures from immune donors but not in cultures from nonimmune newborns or adults.
Production of y-inteij%on by enriched Leu

DISCUSSION
Our results extend previous observations by showing that HSV alone is a sufficient stimulus for the release of 2-10 U/ml of yinterferon by lo6 MNC from nonimmune donors, whether newborn or adult. These amounts of y-interferon are small compared with the 90-1 10 U/ml of y-interferon made by lo6 MNC from immune donors. The difference must in part result from the presence of HSV-specific T cells in the MNC from immune donors since these cells are known to release y-interferon following activation (17) . Antigen-activated T cells also release IL 2 and to determine what effect this might have on y-interferon production by newborn cells we added recombinant IL 2 to the cultures of newborn and adult nonimmune donors. In each case more y-interferon was obtained in the IL 2 than in the HSVstimulated cultures, with a synergistic effect in cultures containing both. HSV alone was, in contrast, sufficient to induce maximal amounts of y-interferon production by the immune donors' MNC, most probably because the antigen stimulus elicits the production of 1-5 U/ml of IL 2 (previous unpublished results).
The MNC subset manipulation experiments suggested that Leu 1 I + cells were necessary for y-interferon production by the nonimmune cells. Whether Leu 1 I + cells are also sufficient for y-interferon production is less certain in that the amounts of yinterferon we recovered from large granular lymphocyte-enriched preparations were proportionally rather less than were made by unseparated cells. This difference may well be an artefact of the separation or culture conditions in that previous studies in which monocytes were added back to Percoll separated human large granular lymphocytes showed no requirement for monocytes for either LY (14) or y-interferon (6) production.
Mouse spleen cells, in contrast, do appear to require the presence of macrophages for optimal y-interferon production in response to IL 2 (18) .
The Sephadex G 10 separations we performed to explore this possibility suggested that the predominant effect of adherent cells (newborn or adult) on y-interferon production was suppressive: both background and IL 2 stimulated y-interferon levels were higher after depletion of adherent cells. This monocyte-mediated y-interferon suppression has been observed previously and was recently attributed to in vitro prostaglandin E synthesis (12) .
Presently available data suggest that monocytes are not necessary for y-interferon synthesis by human MNC. The percentage of Leu 1 1' cells in newborn and adult cultures was always higher in cultures that had been stimulated with IL 2 + HSV than either alone. This increase was also found when Leu 11 cells were depleted from the cells before culture by antibody and complement. Possible explanations for the increase include rapid proliferation of a small remaining subset, or the induction of the Leu 11 antigen on previously negative cells under these culture conditions. Propidium iodide staining of the Leu 1 I + cells gave no indication that they had moved out of Go (Leibson PA, personal communication), so rapid proliferation seems unlikely. The possibility that the antigen is newly induced on cells during the culture period remains to be excluded.
The ability of IL 2 alone to induce y-interferon release by MNC from mature animals has been reported previously (15, 18) and it complicates the interpretation of previous reports where HSV antigen was used to stimulate y-interferon production. Green et al. (19) , for example, found high levels of yinterferon in the culture supernatants of nonimmune adult donors' MNC stimulated with UV inactivated HSV for 48 h. Little y-interferon was found in these cultures after 5 days' incubation where the cultures had been washed at 48 h. Factors that may have interfered with these workers' detection of y-interferon production by nonimmune donors MNC include the use of fetal calf serum as a medium supplement (this would tend to activate T cells nonspecifically and raise the background response), the use of inactivated virus and the intermediate washing step which would remove IL 2.
Our observations suggest that newborn NK cells with the Leu 1 I+ phenotype are, like adult cells (20) , capable of recognizing HSV antigens and that their ability to make y-interferon is limited not by intrinsic immaturity but by the availability of IL 2. While newborn T cells can make IL 2 in the same amounts as adult cells following nonspecific activation by mitogens (2 1) the frequency of HSV-responsive T cells at birth is less than 1: lo6 (3) and HSV antigen stimulation does not result in the release of IL 2. HSV-specific T cells, however, are unlikely to be responsible for the reduction in susceptibility to severe HSV infections which takes place in the first weeks of life as this occurs without the spontaneous development of HSV-specific immunity. Whether the generation of T cells of other specificities as a result of environmental exposure provides cells which can be recruited into NK cell responses as bystanders and provide IL 2, or whether IL 2 is supplied by increasingly mature NK cells themselves (8) is not yet known.
